T

T2 Biosystems
D

TTOO

0.22990
USD
-0.02
(-8.04%)
Market Closed
Volume
2,478
EPS
-1
Div Yield
-
P/E
-8
Market Cap
4,837,775
Related Instruments
    ABT
    ABT
    0.970
    (0.83%)
    117.780 USD
    A
    ALGN
    4.180
    (1.83%)
    232.180 USD
    B
    BAX
    0.335
    (1.06%)
    31.825 USD
    BDX
    BDX
    -2.330
    (-0.97%)
    237.930 USD
    BSX
    BSX
    -0.570
    (-0.57%)
    100.300 USD
    EW
    EW
    -0.910
    (-1.30%)
    69.040 USD
    ISRG
    ISRG
    6.68
    (1.11%)
    610.50 USD
    MDT
    MDT
    -0.550
    (-0.62%)
    87.850 USD
    WST
    WST
    3.29
    (0.95%)
    347.85 USD
    ZBH
    ZBH
    -0.890
    (-0.80%)
    109.710 USD
    More
News

Title: T2 Biosystems

Sector: Healthcare
Industry: Diagnostics & Research
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.